ConforMIS to Present at Canaccord Genuity and Morgan Stanley Conferences
ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today its participation in two upcoming investment conferences:
Canaccord Genuity Musculoskeletal Conference, March 19, 2013,1:10 p.m. CT, The Westin Michigan Avenue, Chicago, Ill. — Dr. Philipp Lang, CEO of ConforMIS, will present an update on the company and provide an overview of the company’s personalized technology platform, including the iTotal® G2 patient-specific total knee replacement system.
Canaccord Genuity Musculoskeletal Conference, March 19, 2013,1:10 p.m. CT, The Westin Michigan Avenue, Chicago, Ill. — Dr. Philipp Lang, CEO of ConforMIS, will present an update on the company and provide an overview of the company’s personalized technology platform, including the iTotal® G2 patient-specific total knee replacement system.